Transfusion therapy in congenital coagulopathies
- PMID: 7860443
Transfusion therapy in congenital coagulopathies
Abstract
Transfusion therapy for the congenital coagulopathies has changed considerably in recent years. Improved donor screening, purification, and virucidal methodologies have resulted in much safer plasma-derived clotting factor concentrates. Additionally, synthetic products such as rF VIII and DDAVP are licensed and available. For persons with hemophilia B, nonthrombogenic coagulation F IX concentrates are available. Treatment recommendations for each of the congenital coagulopathies are discussed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical